[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Universidad Nacional de Colombia\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":167},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,41,74,106,138],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100625695","phase-3-transverse-vs-longitudinal-mucosal-incision-during-poem-100625695",false,"NCT07425977","Transverse vs Longitudinal Mucosal Incision During POEM","Transverse Versus Longitudinal Mucosal Incision in Peroral Endoscopic Myotomy: A Multicenter Randomized Clinical Trial","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Diagnosis of achalasia or other spastic esophageal motility disorders with an indication for POEM\n* ASA physical status I-III\n* Ability to provide informed consent\n\nExclusion Criteria:\n\n* Prior myotomy or major esophageal surgery\n* Uncorrectable coagulopathy\n* Pregnancy\n* Active systemic infection\n* Contraindication to anesthesia\n* Any situation predicting technical inability to perform POEM","ALL","18 Years",{"count":19,"type":20},140,"ESTIMATED","INTERVENTIONAL",[23],"PHASE3","Peroral endoscopic myotomy (POEM) is a minimally invasive endoscopic procedure used to treat achalasia and other spastic esophageal motility disorders. A key step in POEM is creating a small opening in the esophageal lining (mucosal incision) to enter the submucosal tunnel. This study evaluates whether making that entry incision \\*\\*transverse\\*\\* (across the esophagus) versus \\*\\*longitudinal\\*\\* (along the esophagus) improves procedural efficiency without reducing safety.\n\nThis is a \\*\\*multicenter, randomized (1:1), parallel-group clinical trial\\*\\* conducted in three therapeutic endoscopy units in Colombia (Hospital Universitario del Valle and Clínica Versalles in Cali, and Clínica del Occidente in Bogotá). Adults (≥18 years) with an indication for POEM, ASA I-III, and ability to provide informed consent will be eligible; key exclusions include prior myotomy\u002Fmajor esophageal surgery, uncorrectable coagulopathy, pregnancy, active systemic infection, anesthesia contraindication, or anticipated technical inability to perform POEM.\n\nAll procedures are standardized: POEM under \\*\\*general anesthesia with orotracheal intubation\\*\\*, \\*\\*CO₂ insufflation\\*\\*, validated endoscopic knives and preset electrosurgical modes; hemostasis with \\*\\*Coagrasper® only if needed\\*\\*; and closure using standard \\*\\*through-the-scope (TTS) clips\\*\\*. Participants are randomly assigned to a \\*\\*15 mm transverse mucosal incision\\*\\* (perpendicular to the esophageal axis) or a \\*\\*15 mm longitudinal mucosal incision\\*\\*. Full-procedure video is recorded for quality control and to allow objective timing, with blinded assessment of the primary outcome.\n\nThe \\*\\*primary outcome\\*\\* is the time (seconds) from the first mucosal cut to successful entry of the endoscope cap into the submucosal tunnel (advancing at least 1 cm). \\*\\*Secondary outcomes\\*\\* include need for hemostasis with Coagrasper®, number of clips required for complete closure, and early complications (including perforation and gas-related events such as capnoperitoneum requiring decompression and emphysema), monitored through \\*\\*30 days\\*\\*.\n\nParticipants complete a screening\u002Fpreoperative visit (up to 30 days before), undergo the POEM procedure, have early in-hospital\u002Fdischarge assessment (days 1-2), and receive safety follow-up contacts at approximately 1 week and day 30.\n\nRisks are those expected from standard POEM and peri-anesthesia care (e.g., bleeding, perforation, infection, and gas-related complications), and participants may not directly benefit clinically. However, the transverse incision may shorten access and closure time and reduce resource use without increasing short-term complications.\n\nThe study will be conducted with written informed consent, confidentiality protections (pseudonymization and secure storage), and reporting of results in aggregate form.",[26,27],"Esophageal Achalasia","Spastic Esophageal Motility Disorders","NOT_YET_RECRUITING","2026-02-20",{"date":31,"type":32},"2026-02-24","ACTUAL",{"date":34,"type":20},"2026-02-22",{"date":36,"type":20},"2026-08-02",{"name":38,"class":39},"Universidad Nacional de Colombia","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":49,"minAge":17,"maxAge":50,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":40},"100531117","phase-1-personalized-vaccine-for-tnbc-immunotherapy-100531117","NCT06195618","Personalized Vaccine for TNBC Immunotherapy","ESTUDIO CLÍNICO FASE I DE INMUNOTERAPIA CON VACUNAS SINTÉTICAS PERSONALIZADAS EN PACIENTES CON CÁNCER DE MAMA TRIPLE NEGATIVO","TEBICA003 TNBC","Inclusion Criteria:\n\n1. Be between 18 and 75 years of age.\n2. Histologically confirmed diagnosis of primary triple negative breast carcinoma (TNBC).\n3. Patients who have already been treated, either with chemo\u002Fradiotherapy and\u002For surgery regimens, and in whom, according to previous preclinical studies, it was possible to clearly identify tumor NEOANTIGENS expressed by their tumor.\n4. Have frank venous access.\n5. Have a functional status (Karnofsky Scale) greater than 70%.\n6. Weight equal to or greater than 50 kilograms.\n7. The chemical synthesis of at least one tumor NEOANTIGEN expressed exclusively by your tumor was successful.\n8. The apheresis procedure successfully allowed the obtaining of sufficient white blood cells to obtain leukocytes necessary for functional tests and for the derivation of dendritic cells.\n\nExclusion Criteria:\n\n1. Active and\u002For uncontrolled cardiovascular disease.\n2. You are pregnant or breastfeeding.\n3. Has associated medical comorbidities such as diabetes or kidney failure, or coagulation disorders.\n4. You have been hospitalized in the last month.\n5. Has another active primary tumor except for skin tumors.\n6. Patients who are linked to another clinical study.\n7. Patients with a history of infectious diseases such as HIV, Hepatitis, tuberculosis.\n8. Consumption of immunosuppressive medications such as corticosteroids (except topical).","FEMALE","75 Years",{"count":52,"type":20},8,[54],"PHASE1","Due to their genetic instability, breast tumors that do not express receptors for Estrogens, Progestagens or amplify the Her2 \u002F neu oncogene \\[called triple-negative breast cancer (TNBC)\\] and other tumors such as melanoma, non-small cell lung cancer, accumulate numerous mutations that make them highly resistant to different regimens of chemo- or radiotherapy, thereby generating high morbidity and mortality. However, immunology can turn the genetic instability of tumors into the Achilles' tendon. Evidence of this has been revealed in Phase I clinical studies in patients with melanoma and lung cancer in an advanced stage of metastasis treated with Ipilimumab (anti-CTLA4) to decrease immunosuppression, in whom peptides containing mutations presented in Major Complex molecules Histocompatibility of Class I (MHC I) of the tumor itself results in their recognition as \"foreign\" neo-antigens leading to the efficient destruction of the tumor by anti-tumor CD8 + T lymphocytes that are amplified when they are vaccinated with these peptides.\n\nFor this reason, the identification of non-synonymous mutations of single amino acid and vaccination with 25 amino acid peptides that incorporate these mutations (synthetic vaccines) is emerging today as an alternative for immunotherapy of cancers responsible for high mortality in humans. In an approach that takes 16 weeks, today, it is possible to go from the analysis of the tumor's transcriptome (which allows identifying the universe of tumor mutations) to the patient's vaccination with a personalized vaccine that contains neo-antigens of his tumor.\n\nTNBC is the most aggressive breast tumor, representing around 15% of breast cancers in our environment. While generally, at least 30% of women with other types of metastatic breast cancer survive 5 years after diagnosis, most patients diagnosed with metastatic TNBC die within this time. The lack of selective therapies and the poor prognosis of patients with TNBC make their therapeutic management difficult, so the implementation of new therapies for this type of tumor is the main focus of researchers who seek more effective and selective treatments to improve the life expectancy of patients without compromising their quality of life. The genetic instability and high rate of mutations of the TNBC most likely favor the generation of neo-epitopes. Still, due to the immunosuppressive environment of the tumor, it escapes the immunosurveillance of the immune system. Despite the high mortality induced by this tumor, a percentage of patients treated with neoadjuvant chemotherapy with agents such as Doxorubicin and Cyclophosphamide (AC) + Taxanes respond to this chemotherapy regimen. In particular, the anti-tumor effect of AC is attributed to two things: (i) the direct cytotoxic effect on the tumor cell, (ii) the immunostimulation of T lymphocytes promoted by Immunogenic Cell Death (ICD) selectively induced by these drugs. Therefore, in this project, we propose to carry out the first clinical study in Colombia of vaccination of patients with TNBC with synthetic peptides that contain mutations of their own tumor to evaluate the immunogenicity and safety of this type of personalized vaccine as a therapeutic alternative for this tumor. Achieving the specific objectives set out in this project would mean that we have been validated in Colombia the experimental design necessary to identify unique epitopes in tumors and demonstrate the safety and immunogenicity of these vaccines. We consider that having achieved the above; we will have taken an important step towards the implementation in our country of the use of this type of vaccine for immunotherapy not only of TNBC but of other tumors such as glioblastoma, gastric, esophagus, and pancreas, highly fatal due to its high mutation rate.",[57],"Breast Cancer Female",[59,60,61,62,63,64,65],"Triple negative breast cancer","Neo-adjuvant chemotherapy","Dendritic cells","Peptide","Immunotherapy","Immune-monitoring","Personalized vaccines","2025-06-18",{"date":68,"type":32},"2025-06-25",{"date":70,"type":20},"2025-08-01",{"date":72,"type":20},"2028-06-01",{"name":38,"class":39},{"id":75,"slug":76,"hasResults":11,"nctId":77,"briefTitle":78,"officialTitle":79,"acronym":4,"eligibilityCriteria":80,"healthyVolunteers":81,"sex":16,"minAge":82,"maxAge":83,"enrollmentInfo":84,"targetDuration":4,"studyType":21,"phases":86,"briefSummary":88,"conditions":89,"keywords":92,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":40},"100587540","effect-of-an-educational-intervention-on-cpr-knowledge-and-skills-in-schoolchildren-100587540","NCT06929715","Effect of an Educational Intervention on CPR Knowledge and Skills in Schoolchildren","Effect of an Educational Intervention on CPR Knowledge and Skills in 7- and 8-Year-Old Schoolchildren: A Non-Randomized Controlled Trial","Inclusion Criteria:\n\n* Schoolchildren aged between 7 and 8 years.\n* Students enrolled in an educational institution that has authorized their participation in the study.\n* Not participating in any other intervention or educational program related to CPR during the study period.\n\nExclusion Criteria:\n\n* Students whose parents, legal guardians, teachers, or the students themselves report any health condition that prevents them from participating in the study.\n* Students who indicate having received prior training in CPR or related skills.\n* Students whose parents, legal guardians, or teachers report any cognitive condition that limits their ability to understand and follow the instructions necessary to learn and practice CPR in simulated scenarios.",true,"7 Years","8 Years",{"count":85,"type":20},388,[87],"NA","This study aims to evaluate the effectiveness of a CPR intervention for children aged 7 and 8. Given the high prevalence of out-of-hospital cardiac arrests (OHCA) and the proven benefits of early CPR training, the study seeks to determine whether a structured intervention can improve young children's knowledge and skills in basic life support.\n\nWhat is the effect of a CPR training intervention on the knowledge and skills of 7- and 8-year-old schoolchildren?\n\nCardiac arrest is a leading cause of mortality worldwide. Research shows that survival rates increase significantly when CPR is performed promptly by a trained bystander. Countries with early CPR training programs in schools, such as Norway and Denmark, report better survival outcomes. However, in Latin America, CPR education in schools is still in its early stages. Evidence suggests that children can effectively learn and retain CPR knowledge, and they can serve as multipliers by passing their knowledge to family and peers.\n\nStudy Design:\n\nThis is a non-randomized, double-blind controlled trial with four phases:",[90,91],"CPR","Cardiac Arrest (CA)",[93,94,95,96,97],"schoolchildren","learning","intervention","knowledge","skills","2025-04-08",{"date":100,"type":32},"2025-04-16",{"date":102,"type":20},"2025-05-01",{"date":104,"type":20},"2025-09-01",{"name":38,"class":39},{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":4,"eligibilityCriteria":112,"healthyVolunteers":81,"sex":16,"minAge":113,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":21,"phases":117,"briefSummary":118,"conditions":119,"keywords":123,"overallStatus":129,"whyStopped":4,"lastUpdateSubmitDate":130,"lastUpdatePostDateStruct":131,"startDateStruct":133,"completionDateStruct":135,"leadSponsor":137,"locationsCount":40},"100514538","effectiveness-of-two-health-education-interventions-in-the-prevention-of-caries-and-gingivitis-in-orthodontic-patients-100514538","NCT05979805","Effectiveness of Two Health Education Interventions in the Prevention of Caries and Gingivitis in Orthodontic Patients","Effectiveness of Motivational Interviewing and Conventional Oral Health Education (OHEc) Versus OHEc in the Prevention and Control of Dental Caries and Gingivitis in Subjects With Fixed Orthodontic Appliances. A Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients enrolled in the different orthodontic postgraduate clinics of the National University of Colombia who requires treatment with fixed orthodontic appliances\n* 13 years old up to 28 years of age.\n* Willingness to participate in the study and signature of the informed consent form.\n\nExclusion Criteria:\n\n* Patients with untreated caries lesions\n* Patients with periodontal diseases or experience\n* Previous orthodontics treatments\n* Severe fluorosis or enamel abnormalities.\n* Medical compromise or treatments generating hyposalivation or gingival enlargement\n* Craniomaxillary anomalies\n* Cognitive or motor disability\n* Pregnancy.\n* Dependence to alcohol, nicotine or psychoactive substances","13 Years","28 Years",{"count":116,"type":20},94,[87],"Dental caries and gingivitis are classified by the World Health Organization (WHO) as an important public health problem due to their high prevalence and incidence worldwide despite the development of public policies to combat them. They are chronic diseases that have a severe impact in terms of pain and suffering, impairment of function and effect on quality of life. During orthodontic treatments, the most common adverse event is the appearance of dental caries lesions and gingivitis due to increased retention and change of dental biofilm composition or difficulty of removal with conventional oral hygiene techniques. Efforts to implement various conventional preventive interventions of self-care and education have not decreased their incidence, so it is necessary to implement motivational interventions to help adolescents and young adults to make positive changes in their oral health habits, which are constant and lasting and prevent and control gingivitis and caries.",[120,121,122],"Dental Caries","Tooth Demineralization","Gingivitis",[124,125,126,127,128],"Adolescent,Teenagers,Young Adult,Adult",""Motivational Interviewing"[Mesh]",""Health Education, Dental"[Mesh]",""Orthodontic Appliances"[Mesh]",""Orthodontic Appliances, Fixed"[Mesh]","RECRUITING","2025-03-15",{"date":132,"type":32},"2025-03-19",{"date":134,"type":32},"2024-04-15",{"date":136,"type":20},"2026-04-20",{"name":38,"class":39},{"id":139,"slug":140,"hasResults":11,"nctId":141,"briefTitle":142,"officialTitle":143,"acronym":144,"eligibilityCriteria":145,"healthyVolunteers":81,"sex":16,"minAge":17,"maxAge":146,"enrollmentInfo":147,"targetDuration":4,"studyType":149,"phases":4,"briefSummary":150,"conditions":151,"keywords":156,"overallStatus":129,"whyStopped":4,"lastUpdateSubmitDate":160,"lastUpdatePostDateStruct":161,"startDateStruct":163,"completionDateStruct":165,"leadSponsor":166,"locationsCount":40},"100555912","risk-of-sudden-cardiac-death-in-un-athletes-100555912","NCT06518252","Risk of Sudden Cardiac Death in UN Athletes","Detection of the Risk of Sudden Cardiac Death in Athletes From the Universidad Nacional de Colombia","Suddendeath","Inclusion Criteria:\n\n* Athletes belonging to the sports teams of the National University of Colombia, Bogotá campus.\n* Subject's sports history (practice time exceeding 2 years).\n* Individuals aged 18 to 35 years, without discrimination based on biological sex.\n* Training time exceeding 6 hours per week in their sports modality (weekly training record).\n* Personal history of cardiovascular disease (cardiac malformations or previously detected sudden death risk).\n* Athletes who attend at least 90% of the training sessions planned by the coach.\n\nExclusion Criteria:\n\n* Personal history of metabolic (type 1 and 2 diabetes mellitus), neurological (spinal cord injury), or renal disease.\n* Routine consumption of alcohol or psychoactive substances.\n* Use of antihypertensive medications, beta-blockers, or inotropes.\n* Cardiovascular disease diagnosed with previously established pharmacological management.","35 Years",{"count":148,"type":20},250,"OBSERVATIONAL","The detection of sudden cardiac death risk in athletes is a topic of great relevance in the field of sports physiotherapy and physical activity. High-performance sports practice involves anatomical and physiological changes that can modify the mechanical and electrical properties of the heart, increasing the risk of potentially fatal cardiac events. Therefore, it is essential to implement early detection strategies to identify at-risk athletes and prevent tragedies during sports practice.\n\nMethodology: This study focuses on the prevalence of sudden cardiac death risk, using a 12-lead electrocardiogram as the primary detection tool. This examination will allow for the evaluation of the heart's electrical activity and the detection of potential anomalies that could predispose athletes to adverse cardiac events during sports practice. In addition to the electrocardiogram, cardiovascular screening questionnaires will be administered to collect information on personal and family health histories, as well as other relevant risk factors. In conjunction with the project's researchers, the sports medical team of the Universidad Nacional de Colombia will be responsible for conducting the evaluations, ensuring the precision and reliability of the obtained results. A detailed analysis of the collected data will be performed using statistical tools to identify possible correlations between the evaluated risk factors and the presence of sudden cardiac death risk in athletes. Logistic regression models will be employed to determine the strength of association between the studied variables and cardiovascular risk in this specific population.\n\nExpected Results: It is anticipated that implementing pre-participation evaluations, including the electrocardiogram and cardiovascular screening questionnaires, will enable the identification of athletes at higher risk of sudden cardiac death. These results will allow for the establishment of individualized risk profiles and the design of personalized prevention strategies for each athlete. Additionally, it is expected that the findings of this study will contribute to the development of early detection protocols for sudden cardiac death risk in athletes, which can be effectively implemented in sports settings. The information generated from this study will provide a solid foundation for clinical decision-making and the implementation of preventive measures to benefit the health and well-being of high-performance athletes.",[152,153,154,155],"Death, Sudden, Cardiac","Electrocardiogram QT Prolonged","Athlete Heart","Athletic Injuries",[157,158,159],"Sudden death of the athlete","Electrocardiogram","University sports.","2024-07-18",{"date":162,"type":32},"2024-07-24",{"date":164,"type":32},"2023-11-24",{"date":68,"type":20},{"name":38,"class":39},""]